Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Chronic liver injury characteristically results in hepatic inflammation, which represents a prerequisite for organ fibrosis. Although NKT cells are abundantly present in liver and involved in hepatic inflammation, molecular mechanisms of their recruitment in liver fibrosis remained elusive. We hypothesized that chemokine receptor CXCR6 and its ligand CXCL16 control NKT cell migration and functionality in liver fibrosis. In patients with chronic liver diseases (n = 58), CXCR6 and CXCL16 expression was intrahepatically upregulated compared with controls. In murine liver, Cxcl16 was strongly expressed by endothelium and macrophages, whereas lymphocyte populations (NKT, NK, CD4 T, CD8 T cells) expressed CXCR6. Intravital two-photon microscopy imaging of Cxcr6+/gfp and Cxcr6gfp/gfp mice and chemotaxis studies in vitro revealed that CXCR6 specifically controls hepatic NKT cell accumulation during the early response upon experimental liver damage. Hepatic invariant NKT cells expressed distinct proinflammatory cytokines including IFN-γ and IL-4 upon injury. CXCR6-deficient mice were protected from liver fibrosis progression in two independent experimental models. Macrophage infiltration and protein levels of inflammatory cytokines IFN-γ, TNF-α, and IL-4 were also reduced in fibrotic livers of Cxcr6−/− mice, corroborating that hepatic NKT cells provide essential cytokine signals perpetuating hepatic inflammation and fibrogenesis. Adoptive transfer of NKT cells, but not CD4 T cells, isolated from wild type livers restored hepatic fibrosis in Cxcr6−/− mice upon experimental steatohepatitis. Our results demonstrate that hepatic NKT cells accumulate CXCR6-dependent early upon injury, thereby accentuating the inflammatory response in the liver and promoting hepatic fibrogenesis. Interfering with CXCR6/CXCL16 might therefore bear therapeutic potential in liver fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this model, fibrosis amelioration appeared to depend on effects on NK-cells rather than direct modulation of macrophages, although macrophage phenotypes were not extensively characterized.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [87]
In the citing paper
“A similar protective effect was observed in a MASH model, supporting the relevance of intercellular crosstalk in shaping macrophage function.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [87]
In the citing paper
“C-X-C chemokine receptor 6 (CXCR6) is mainly expressed in natural killer (NK) cells, whereas its ligand CXCL16 is expressed in macrophages and endothelial cells, and both are also upregulated in patients with chronic liver disease.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [87]
In the citing paper
“Mechanistically, several ligand-receptor pairs mediate the effects of NKT cells, including LIGHT-HVEM (which promotes hepatocyte steatosis) and CXCL16-CXCR6 (which promotes hepatic NKT cell recruitment and liver fibrosis).93,94”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [94]
In the citing paper
“NKT cells are much more abundant in mouse livers than in humans, and they promote NASH, fibrosis and carcinogenesis in experimental models.86,96,97”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [97]
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
The Liver as an Immunological Organ
Racanelli, V., & Rehermann, B. (2006) · Hepatology · doi:10.1002/hep.21060 · Cited by 1,377
Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation
McDonald, B., Pittman, K., Menezes, G. B., Hirota, S. A., Slaba, I., Waterhouse, C. C. M., Beck, P. L., Muruve, D. A., & Kubes, P. (2010) · Science · doi:10.1126/science.1195491 · Cited by 1,210 · cited 1×
“have applied this method for liver in living mice, mostly because of artifacts created by breath movements and the autofluorescence of hepatic tissue (27, 30).”
MethodGodfrey, D. I., MacDonald, H. R., Kronenberg, M., Smyth, M. J., & Kaer, L. V. (2004) · Nature Reviews Immunology · doi:10.1038/nri1309 · Cited by 1,182 · cited 6×
“ferent types of proinflammatory cytokines, including IL-4, IFN-g, and TNF-a (14).”
BackgroundInfluentialTracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers
Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C.-R., Koezuka, Y., & Kronenberg, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.741 · Cited by 887 · cited 1×
“Ab or a-GalCer (17), resulting in low hepatic NKT cell numbers in chronic injury, such as fibrosis (12).”
BackgroundKarlmark, K. R., Weiskirchen, R., Zimmermann, H. W., Gassler, N., Ginhoux, F., Weber, C., Merad, M., Luedde, T., Trautwein, C., & Tacke, F. (2009) · Hepatology · doi:10.1002/hep.22950 · Cited by 782 · cited 2×
“Hepatocytes were isolated from murine livers by conventional collagenase perfusion methodology (6).”
BackgroundMethodSelf-citationIntravascular Immune Surveillance by CXCR6+ NKT Cells Patrolling Liver Sinusoids
Geissmann, F., Cameron, T. O., Sidobre, S., Manlongat, N., Kronenberg, M., Briskin, M. J., Dustin, M. L., & Littman, D. R. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030113 · Cited by 680 · cited 7×
“(15) and in macrophages or dendritic cells of other organs (22).”
BackgroundResultInfluentialBaeck, C., Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300304 · Cited by 609 · cited 4×
“Biochemical assays and gene and protein expression studies were performed as described previously (8, 24, 25).”
MethodInfluentialSelf-citation
Cited by
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Griffith, J. W., Sokol, C. L., & Luster, A. D. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120145 · Cited by 2,059
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Hepatic stellate cells as key target in liver fibrosis
Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424
Self-citationLiver fibrosis and repair: Immune regulation of wound healing in a solid organ
Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3623 · Cited by 1,310
Immunology in the liver — from homeostasis to disease
Heymann, F., & Tacke, F. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.200 · Cited by 1,180
Self-citationMacrophage heterogeneity in liver injury and fibrosis
Tacke, F., & Zimmermann, H. W. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.025 · Cited by 1,061
“On the one hand, hepatic macrophages interact with other immune cells; for instance, they secrete the chemokine CXCL16 that attracts NKT cells, which in turn can activate pro-inflammatory signals in macrophages [13].”
BackgroundSelf-citationTargeting hepatic macrophages to treat liver diseases
Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.026 · Cited by 1,003
Self-citationThe Chemokine System in Innate Immunity
Sokol, C. L., & Luster, A. D. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016303 · Cited by 862
“NKT cells have similarly been shown to initially migrate into the acutely inflamed liver via a CXCR6-dependent process where they then promote local accumulation of monocytes and macrophages (Wehr et al. 2013).”
BackgroundRoles for chemokines in liver disease
Marra, F., & Tacke, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.06.043 · Cited by 829
Self-citationHepatic inflammatory responses in liver fibrosis
Hammerich, L., & Tacke, F. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00807-x · Cited by 803
“CXCR6-deficient mice show reduced accumulation of NKT cells and are protected from liver fibrosis progression in different models of experimental fibrosis 54 .”
Self-citationWen, Y., Lambrecht, J., Ju, C., & Tacke, F. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00558-8 · Cited by 695
Self-citationPeiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.012 · Cited by 564
Self-citationTumor‐associated macrophages in liver cancer: From mechanisms to therapy
Cheng, K., Cai, N., Zhu, J., Yang, X., Liang, H., & Zhang, W. (2022) · Cancer Communications · doi:10.1002/cac2.12345 · Cited by 460
“Similar to pro-inflammatory M1 macrophages, Ly6Chigh MoMφs can exacerbate inflammation and fibrogenesis [55].”
BackgroundNon-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
Musso, G., Cassader, M., & Gambino, R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.3 · Cited by 412
Liver inflammation abrogates immunological tolerance induced by Kupffer cells
Heymann, F., Peusquens, J., Ludwig‐Portugall, I., Kohlhepp, M., Ergen, C., Niemietz, P., Martin, C., van Rooijen, N., Ochando, J. C., Randolph, G. J., et al. (2015) · Hepatology · doi:10.1002/hep.27793 · Cited by 398
“Intravital microscopy was performed as described earlier.(18) Cellular mobility was monitored by video microscopy over a minimum time period of 2-3 hours imaging multiple view fields.”
MethodSelf-citationAdaptive immunity: an emerging player in the progression of NAFLD
Sutti, S., & Albano, E. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0210-2 · Cited by 374
IL-2high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection
Pallett, L. J., Davies, J., Colbeck, E. J., Robertson, F., Hansi, N., Easom, N. J. W., Burton, A. R., Stegmann, K. A., Schurich, A., Swadling, L., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162115 · Cited by 347
“PBMCs from healthy controls at 3 × 105 cells/well were incubated with either (i) 5, 10, or 50 ng/ml of recombinant human (rh) IL-15, TGFβ, IL-7, IL-33, CXCL16, IL-6, or IL-12 (R&D Systems) or combinations of these for cytokine induction; (ii) 0.25 µg/ml immobilized anti-CD3 (eBioscience) for 24 h and then rested for a…”
BackgroundInfluentialLiedtke, C., Luedde, T., Sauerbruch, T., Scholten, D., Streetz, K., Tacke, F., Tolba, R., Trautwein, C., Trebicka, J., & Weiskirchen, R. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-19 · Cited by 335
“Interfering with CXCR6/CXCL16 might therefore bear therapeutic potential in liver fibrosis [208].”
BackgroundSelf-citationT Cells in Fibrosis and Fibrotic Diseases
Zhang, M., & Zhang, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01142 · Cited by 330
“Th17 Lung Mouse S. rectivirgula-induced lung fibrosis Pro-fibrotic (36) Treg Lung Mouse Bleomycin-induced pulmonary fibrosis Anti-fibrotic (37) Treg Heart Mouse Angiotensin II-infused hypertension Anti-fibrotic (38) Treg Lung Mouse Silica-induced lung fibrosis Pro-fibrotic (39) Treg Heart Mouse MI Pro-fibrotic (40) Tr…”
BackgroundInfluentialAn integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
Tacke, F., Puengel, T., Loomba, R., & Friedman, S. L. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.038 · Cited by 321
Self-citationImmunity, tolerance and autoimmunity in the liver: A comprehensive review
Doherty, D. G. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.08.020 · Cited by 314
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells
Ruf, B., Heinrich, B., & Greten, T. F. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00572-w · Cited by 312
“Hepatic NKT cells preferentially express the chemokine receptor CXCR6 and are recruited to the liver in the early phases of inflammation and liver injury.(141) The antitumor properties of NKT cells in HCC were also demonstrated by the fact that CXCR6 deficiency leads to reduced numbers of TNFα- and IFNγ-expressing NKT…”
BackgroundLiver regeneration and inflammation: from fundamental science to clinical applications
Campana, L., Esser, H., Huch, M., & Forbes, S. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00373-7 · Cited by 307
Weiskirchen, R., & Tacke, F. (2014) · PubMed · doi:10.3978/j.issn.2304-3881.2014.11.03 · Cited by 256
“While NK cells are important for killing virally infected or transformed hepatocytes (170), NKT cells patrol the liver and are capable of rapidly aggravating inflammatory responses in conditions of injury (171).”
BackgroundSelf-citationVerbeke, L., Mannaerts, I., Schierwagen, R., Govaere, O., Klein, S., Vander Elst, I., Windmolders, P., Farre, R., Wenes, M., Mazzone, M., et al. (2016) · Scientific Reports · doi:10.1038/srep33453 · Cited by 236
CXCR6 marks a novel subset of T-betloEomeshi natural killer cells residing in human liver
Stegmann, K. A., Robertson, F., Hansi, N., Gill, U., Pallant, C., Christophides, T., Pallett, L. J., Peppa, D., Dunn, C., Fusai, G., et al. (2016) · Scientific Reports · doi:10.1038/srep26157 · Cited by 235
Immune mechanisms in acetaminophen-induced acute liver failure.
Krenkel, O., Mossanen, J. C., & Tacke, F. (2014) · PubMed · doi:10.3978/j.issn.2304-3881.2014.11.01 · Cited by 219
“Furthermore, macrophages not only exert direct effects on liver parenchymal and non-parenchymal cells, but can also orchestrate responses from other immune cells such as NKT cells (28) or neutrophils (19).”
BackgroundSelf-citationLiver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Parola, M., & Pinzani, M. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101231 · Cited by 218
Keenan, B. P., Fong, L., & Kelley, R. K. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0749-z · Cited by 220
Li, F., Hao, X., Chen, Y., Bai, L., Gao, X., Lian, Z., Wei, H., Sun, R., & Tian, Z. (2017) · Nature Communications · doi:10.1038/ncomms13839 · Cited by 191
The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases
Korbecki, J., Bajdak-Rusinek, K., Kupnicka, P., Kapczuk, P., Simińska, D., Chlubek, D., & Baranowska-Bosiacka, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073490 · Cited by 161
Hepatic Stellate Cells and Hepatocarcinogenesis
Barry, A. E., Baldeosingh, R., Lamm, R. J., Patel, K., Zhang, K., Dominguez, D. A., Kirton, K. J., Shah, A. P., & Dang, H. T. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00709 · Cited by 169
The Endothelium as a Driver of Liver Fibrosis and Regeneration
Lafoz, E., Ruart, M., Anton, A., Oncins, A., & Hernández-Gea, V. (2020) · Cells · doi:10.3390/cells9040929 · Cited by 149
“In addition, activated LSEC contribute to the profibrogenic response by recruiting B cells [119], natural killer T cell (NKT) cells [120] and activating KC [120–122].”
BackgroundWabitsch, S., McCallen, J. D., Kamenyeva, O., Ruf, B., McVey, J. C., Kabat, J., Walz, J. S., Rotman, Y., Bauer, K. C., Craig, A. J., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.010 · Cited by 143
Petrescu, M. D., Vlaicu, S. I., Ciumărnean, L., Milaciu, M. V., Mărginean, C., Florea, M., Vesa, Ș. C., & Popa, M. (2022) · Medicina · doi:10.3390/medicina58050641 · Cited by 174
Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice
Cui, K., Yan, G., Xu, C., Chen, Y., Wang, J., Zhou, R., Bai, L., Lian, Z., Wei, H., Sun, R., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.027 · Cited by 144
“NKT cell accumulation in the liver may be driven by certain cytokines or chemokines [8,35,36].”
BackgroundNiches for the Long-Term Maintenance of Tissue-Resident Memory T Cells
Takamura, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01214 · Cited by 147
Mossanen, J. C., Kohlhepp, M., Wehr, A., Krenkel, O., Liepelt, A., Roeth, A. A., Möckel, D., Heymann, F., Lammers, T., Gassler, N., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.247 · Cited by 125
Self-citationRole of Metabolism in Hepatic Stellate Cell Activation and Fibrogenesis
Hou, W., & Syn, W. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00150 · Cited by 138
Wang, X., Rao, H., Zhao, J., Wee, A., Li, X., Fei, R., Huang, R., Wu, C., Liu, F., & Wei, L. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0342-6 · Cited by 129
Lurje, I., Hammerich, L., & Tacke, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197378 · Cited by 126
“After induction of liver injury in mice, NKT cell accumulation is an early event that promotes sustained tissue inflammation [82]; this inflammatory activity, however, also helps to recognize and remove senescent hepatocytes as a tumor-preventive immune surveillance mechanism [83].”
BackgroundSelf-citationCheng, M. L., Nakib, D., Perciani, C. T., & MacParland, S. A. (2021) · Clinical Science · doi:10.1042/cs20190654 · Cited by 143
Understanding the cellular interactome of non-alcoholic fatty liver disease
Wallace, S. J., Tacke, F., Schwabe, R. F., & Henderson, N. C. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100524 · Cited by 116
“including LIGHT-HVEM (which promotes hepatocyte steatosis) and CXCL16-CXCR6 (which promotes hepatic NKT cell recruitment and liver fibrosis).(93,94) The role of MAIT cells in NASH re-”
BackgroundSelf-citationFunctional Immune Anatomy of the Liver—As an Allograft
Demetris, A. J., Bellamy, C. O. C., Gandhi, C. R., Prost, S., Nakanuma, Y., & Stolz, D. B. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13749 · Cited by 115
“By releasing CXCL16, KC and monocyte-derived macrophages recruit NKT cells after acute liver injury, which increases monocyte infiltration and fibrogenesis (526).”
BackgroundCrosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis
Li, H., Zhou, Y., Wang, H., Zhang, M., Qiu, P., Zhang, M., Zhang, R., Zhao, Q., & Liu, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01169 · Cited by 114
“CXCL16 secreted by KCs triggered the hepatic accumulation of CXCR6 NKT cells, thereby accentuating liver inflammation and fibrosis in murine liver (93).”
BackgroundCai, X., Li, Z., Zhang, Q., Qu, Y., Xu, M., Wan, X., & Lu, L. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13787 · Cited by 111
“Chemokines reported to be released by KCs include CXCL1, CXCL2 and CXCL8, which attract neutrophils,(32) CCL1, CCL2, CCL25 and CX3CL1, which promote the infiltration of bone marrow−derived monocytes,(33-36) and CXCL16, which attract natural killer T cells.(37) We therefore speculate that activated KCs may be the sourc…”
BackgroundLi, Y., Huang, B., Jiang, X., Chen, W., Zhang, J., Wei, Y., Chen, Y., Lian, M., Bian, Z., Miao, Q., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01994 · Cited by 107
“Previous reports have demonstrated that chemokine receptor CXCR6 was involved in lymphocyte recruitment to liver (20).”
BackgroundIntestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy
Wang, Y., Huang, B., Jin, T., Ocansey, D. K. W., Jiang, J., & Mao, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.835005 · Cited by 125
Regulation and functional roles of chemokines in liver diseases
Cao, S., Liu, M., Sehrawat, T. S., & Shah, V. H. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00444-2 · Cited by 104
Is the Macrophage Phenotype Determinant for Fibrosis Development?
Lis-López, L., Bauset, C., Seco-Cervera, M., & Cosín‐Roger, J. (2021) · Biomedicines · doi:10.3390/biomedicines9121747 · Cited by 112
Chemokines and Chemokine Receptors in the Development of NAFLD
Roh, Y., & Seki, E. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_4 · Cited by 105
Role of chemokine pathways in hepatobiliary cancer
Ehling, J., & Tacke, F. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.017 · Cited by 94
Self-citationThe Roles of Liver-Resident Lymphocytes in Liver Diseases
Wang, Y., & Zhang, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01582 · Cited by 86
Role of gamma-delta T cells in liver inflammation and fibrosis
Hammerich, L., & Tacke, F. (2014) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v5.i2.107 · Cited by 86
Self-citationRole of lymphocytes in liver cancer
Mossanen, J. C., & Tacke, F. (2013) · OncoImmunology · doi:10.4161/onci.26468 · Cited by 83
“CXCR6-dependent iNKT cells provide essential pro-inflammatory signals that activate local macrophages and perpetuate inflammation.(36) NKT cells may also exert important functions in antitumor immunity.”
Self-citationCzaja, A. J. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12825 · Cited by 84
CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis
Sutti, S., Locatelli, I., Bruzzì, S., Jindal, A., Vacchiano, M., Bozzola, C., & Albano, E. (2015) · Clinical Science · doi:10.1042/cs20150053 · Cited by 80
Wehr, A., Baeck, C., Ulmer, F., Gassler, N., Hittatiya, K., Luedde, T., Neumann, U. P., Trautwein, C., & Tacke, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112327 · Cited by 79
Self-citationPathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches
Kim, K. H., & Lee, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00485 · Cited by 83
Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance
Roohani, S., & Tacke, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147249 · Cited by 85
“Kupffer cell derived CXCL16 recruits profibrotic NKT cells through its ligand receptor CXCR6 to the site of liver injury [138].”
BackgroundSelf-citationPolonsky, M., Gerhardt, L. M. S., Yun, J., Koppitch, K. A., Colón, K. L., Amrhein, H., Wold, B. J., Zheng, S., Yuan, G., Thomson, M. W., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51186-z · Cited by 101
Yan, M., Cui, Y., & Xiang, Q. (2025) · Theranostics · doi:10.7150/thno.106597 · Cited by 95
CXCL16 in kidney and cardiovascular injury
Izquierdo, M. C., Martín-Cleary, C., Fernández‐Fernández, B., Elewa, U., Sánchez-Niño, M. D., Carrero, J. J., & Ortíz, A. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.04.002 · Cited by 78
“NKT accumulation, in turn, promoted the inflammatory response and liver fibrosis [72].”
BackgroundMolecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
Wang, F.-D., Zhou, J., & Chen, E.-Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.787748 · Cited by 71
“), which in turn cause hepatocyte damage, apoptosis, steatosis, and immune cell infiltration, especially kupffer cells (KCs) (Wehr et al., 2013; Pradere et al., 2013).”
BackgroundPeiseler, M., & Tacke, F. (2021) · Cancers · doi:10.3390/cancers13040730 · Cited by 71
Self-citationHepatic Macrophage as a Key Player in Fatty Liver Disease
Xu, L., Liu, W., Bai, F., Xu, Y., Liang, X., Ma, C., & Gao, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.708978 · Cited by 76
“In fatty liver disease, distinctly heterogeneous populations of macrophages can recognize extracellular stimuli through PRRs, including membrane-bound Toll-like receptors (TLRs) and cytoplasmic nucleotide-binding oligomerization domain-like receptors (NLRs), resulting in the secretion of a large amount of inflammatory…”
BackgroundThe immune landscape in nonalcoholic steatohepatitis
Narayanan, S., Surette, F. A., & Hahn, Y. S. (2016) · Immune Network · doi:10.4110/in.2016.16.3.147 · Cited by 64
“Influx of NKT cells into the liver during NASH is mediated by enhanced expression of the chemokine CXCL16 on endothelial cells and macrophages, which binds CXCR6 on the surface of NKT cells (80).”
BackgroundRole of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity
Gupta, G., Khadem, F., & Uzonna, J. E. (2019) · Cytokine · doi:10.1016/j.cyto.2018.09.004 · Cited by 69
The role of the innate immune system in the development and treatment of hepatocellular carcinoma
Roderburg, C., Wree, A., Demir, M., Schmelzle, M., & Tacke, F. (2020) · Hepatic Oncology · doi:10.2217/hep-2019-0007 · Cited by 69
“Next to these data on HCC, it was reported that NKT promotes liver fibrosis [88,93,94].”
BackgroundSelf-citationCrosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis
Yang, F., Li, H., Li, Y., Hao, Y., Wang, C., Jia, P. P., Chen, X., Ma, S., & Xiao, Z. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108051 · Cited by 78
Liver Injury and the Activation of the Hepatic Myofibroblasts
Jiang, J. X., & Torok, N. J. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0019-6 · Cited by 72
CD11b+CD43hiLy6Clo splenocyte‐derived macrophages exacerbate liver fibrosis via spleen–liver axis
Zhang, S., Wan, D., Zhu, M., Wang, G., Zhang, X., Huang, N., Zhang, J., Zhang, C., Shang, Q., Zhang, C., et al. (2023) · Hepatology · doi:10.1002/hep.32782 · Cited by 75
Matsuda, M., & Seki, E. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111556 · Cited by 62
Feng, X., Feng, B., Zhou, J., Yang, J., Pan, Q., Yu, J., Shang, D., Li, L., & Cao, H. (2025) · Hepatology · doi:10.1097/hep.0000000000000831 · Cited by 60
“[5] Other immune cells such as macrophages, [6 – 8] natural killer T cells, [9,10] CD4 + T cells, [10,11] and dendritic cells [12] play dual roles (pro-fibrotic and anti-fibrotic responses) in both HSC activation and LF.”
New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article
Ebrahimi, H., Naderian, M., & Sohrabpour, A. A. (2016) · Middle East Journal of Digestive Diseases · doi:10.15171/mejdd.2016.29 · Cited by 70
Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH)
Jindal, A., Bruzzì, S., Sutti, S., Locatelli, I., Bozzola, C., Paternostro, C., Parola, M., & Albano, E. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.06.015 · Cited by 62
“Moreover, macrophage interaction with CD4 + helper T-lymphocytes and NKT cells has an important role in sustaining lobular inflammation during the disease progression (Sutti et al., 2014 and Wehr et al., 2013).”
Campisano, S., la Colla, A. B., Echarte, S. M., & Chisari, A. N. (2019) · Nutrition Research Reviews · doi:10.1017/s0954422418000239 · Cited by 68
“In this respect, up-regulation of CXCL16 is accompanied by the production of IL-4 and IFN-γ by NKT cells, which worsens inflammation via macrophage activation((144)).”
BackgroundUllah, A., Din, A. U., Ding, W., Shi, Z., Pervaz, S., & Shen, B. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09800-w · Cited by 65
“In experimental NAFLD, CXCR6 promotes liver inflammation by enhancing the invasion of hepatic NKT cells and inflammatory macrophages [208, 210, 211].”
BackgroundRole of bile acids in liver diseases mediated by the gut microbiome
Shao, J., Ge, T., Chen, S., Wang, G., Yang, Q., Huang, C., Xu, L., & Chen, Z. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i22.3010 · Cited by 67
Nanotechnology in Drug Delivery for Liver Fibrosis
Gu, L., Zhang, F., Wu, J., & Zhuge, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.804396 · Cited by 73
Role of the CXCR6/CXCL16 axis in autoimmune diseases
Bao, N., Fu, B., Zhong, X., Jia, S., Ren, Z., Wang, H., Wang, W., Shi, H. R., Li, J., Ge, F., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110530 · Cited by 65
Tao, X., Zhang, R., Du, R., Yu, T., Yang, H., Li, J., Wang, Y., Liu, Q., Zuo, S., Wang, X., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20212414 · Cited by 65
Macrophages as key regulators of liver health and disease
Papachristoforou, E., & Ramachandran, P. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.006 · Cited by 70
Protective role of melatonin in early‐stage and end‐stage liver cirrhosis
Hu, C., Zhao, L., Tao, J., & Li, L. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14634 · Cited by 60
Ahmad, R. S., Eubank, T. D., Łukomski, S., & Boone, B. A. (2021) · Biomolecules · doi:10.3390/biom11060901 · Cited by 62
Shen, X., Peng, Y., & Li, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01450 · Cited by 54
“The recruitment and migration of peripheral NKT cells into injured liver tissues are controlled by CXCR6–CXCL16 chemokine axis (41), and the production and secretion of CXCL16 by immature cholangiocytes is dependent on Hh signaling (33).”
Natural killer T (NKT) cells in autoimmune hepatitis
Mattner, J. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.09.008 · Cited by 53
Natural killer T cells in liver injury, inflammation and cancer
Wang, H., & Yin, S. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1056738 · Cited by 51
“Hepatic NKT cell recruitment and migration are controlled by CXCR6– CXCL16 chemokine axis, which is up-regulated in patients with chronic liver disease [76].”
BackgroundInfluentialDuval, F., Moreno-Cuevas, J. E., González‐Garza, M. T., Maldonado‐Bernal, C., & Cruz‐Vega, D. E. (2015) · International Journal of Inflammation · doi:10.1155/2015/943497 · Cited by 54
Role of the chemokine system in liver fibrosis: a narrative review
Poulsen, K. L., Ross, C. K. C., Chaney, J., & Nagy, L. E. (2022) · Digestive Medicine Research · doi:10.21037/dmr-21-87 · Cited by 53
“Resident NKT cells expressing CXCR6 migrate in response to the local secretion of CXCL16 (127).”
BackgroundInfluentialThe significance of YKL-40 protein in liver fibrosis
Tao, H., Yang, J., Shi, K., Huang, C., Zhang, L., Lv, X., & Li, J. (2014) · Inflammation Research · doi:10.1007/s00011-013-0698-9 · Cited by 53
Sun, Z., Kim, J. H., Kim, S. H., Kim, H. R., Zhang, K., Pan, Y., Ko, M. K., Kim, B. M., Chu, H., Lee, H. R., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.11.049 · Cited by 48
Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma
Koo, S.-Y., Park, E.-J., & Lee, C.-W. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0480-3 · Cited by 47
Ma, Z., Yu, R., Zhu, Q., Sun, L., Jian, L., Wang, X., Zhao, J., Li, C., & Liu, X. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106035 · Cited by 48
Immune–metabolic interactions in homeostasis and the progression to NASH
Hoogerland, J. A., Staels, B., & Dombrowicz, D. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.07.001 · Cited by 48
Leung, H., Xiong, L., Ni, Y., Busch, A., Bauer, M. W., Press, A. T., & Panagiotou, G. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00398-0 · Cited by 49
RASAL3, a novel hematopoietic RasGAP protein, regulates the number and functions of NKT cells
Saito, S., Kawamura, T., Higuchi, M., Kobayashi, T., Yoshita‐Takahashi, M., Yamazaki, M., Abe, M., Sakimura, K., Kanda, Y., Kawamura, H., et al. (2015) · European Journal of Immunology · doi:10.1002/eji.201444977 · Cited by 44
The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update
Sutti, S., Bruzzì, S., & Albano, E. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1111758 · Cited by 45
“[61,62] Mice immunization up-regulates hepatic IL-15 production, while CD4 T-cell ablation significantly lowered the intrahepatic IL-15 mRNA level.”
Background
Metadata
- Authors
- Wehr, A., Baeck, C., Heymann, F., Niemietz, P. M., Hammerich, L., Martin, C., Zimmermann, H. W., Pack, O., Gassler, N., Hittatiya, K., Ludwig, A., Luedde, T., Trautwein, C., & Tacke, F.
- Affiliations
- Universitätsklinikum Aachen (DE)
- University of Bonn (DE)
- Corresponding author
- Wehr, Alexander
- Baeck, Christer
- Heymann, Felix
- Hammerich, Linda
- Luedde, Tom
- Trautwein, Christian
- Tacke, Frank
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-05
- Volume
- 190
- Issue
- 10
- Pages
- 5226-5236
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2149878896
- Cited by
- 268
- References
- 43
- Citations by year
- 2026: 8 · 2025: 21 · 2024: 20 · 2023: 28 · 2022: 31 · 2021: 32 · 2020: 20 · 2019: 18 · 2018: 20 · 2017: 18 · 2016: 9 · 2015: 20 · 2014: 19 · 2013: 4
- FWCI
- 10.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- CXCR6, CXCL16, NKT cells, liver fibrosis, liver inflammation, chemokine receptors, macrophage infiltration, interferon-gamma, IL-4, TNF-α, steatohepatitis, chronic liver injury
- MeSH terms
- Chemokine CXCL16, Receptors, CXCR6, Animals, Cell Movement, Cells, Cultured, Fatty Liver, Humans, Inflammation, Interferon-gamma, Liver, Liver Cirrhosis, Liver Diseases, Macrophages, Mice, Inbred C57BL, CD4-Positive T-Lymphocytes, Interleukin-4, Up-Regulation, Mice, Knockout, Adoptive Transfer, Hepatocytes, Mice, Receptors, CXCR, Chemokine CXCL6, Natural Killer T-Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.